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Purpose. The purpose of this study is to determine how cold exposure and lower body negative pressure effected cardiovascular
variables. Methods. Eleven males (20.3 years ± 2.7) underwent two 20-minute exposures to LBNP. During the 2 trials, the subjects
were exposed to cold air (10∘ C) (COLD) and to ambient temperature (23∘ C) (AMB). The trials consisted of a 100-minute preLBNP period followed by a 20-minute exposure to LBNP and then a 15-minute recovery period. Cardiovascular variables were
recorded every 30 minutes using bioimpedance. Results. When LBNP was applied during the AMB trials, stroke volume immediately
decreased. During the COLD trial, there was a five-minute delay before the decrease in stroke volume. Heart rate increased
immediately after LBNP initiation during the AMB trials but there was a delay in the increase during the COLD trials. That same
pattern was followed with mean arterial blood pressures. Cerebral oxygenation was significantly lower throughout the COLD trial
as compared to the AMB trials. Six subjects reported symptoms of syncope or presyncope during the AMB trials but there were no
reports of symptoms during the COLD trials. Conclusion. From analysis of this data, cold improved the subject’s tolerance to LBNP.

1. Introduction
Hemorrhage is a leading cause of death in both civilian
and battlefield trauma. Survival rate increases when victims
requiring immediate intervention are correctly identified in
a mass-casualty situation, but methods of prioritizing casualties based on current triage algorithms are severely limited
[1]. Controlled study of acute hemorrhage in humans is not
possible; however, it is possible to safely simulate hemorrhage
by applying negative pressure to the lower extremities. Specifically, lower body negative pressure (LBNP) sequesters blood
from the thorax into dependent regions of the pelvis and
legs, effectively decreasing central blood volume in a similar
fashion to hemorrhage [1].
It is well established that a thermal stressor elicits
physiological responses that alter central blood volume. As
environmental temperature decreases or length of exposure
increases, the body attempts to maintain thermoregulatory

homeostasis via multiple mechanisms [2]. Specifically, the
peripheral vasculature will constrict, shunting warmer blood
to the core to maintain core temperature, the onset of
metabolic heat production, and shivering thermogenesis [2].
When environmental temperature increases, the body will
attempt to maintain thermoregulation through peripheral
vasodilation and sweating [2].
Optimal management of hemorrhage and controlling the
effects of a reduction in central blood volume require recognition and integration of multiple complex physiological
responses. The current therapy, which is warming the patient,
used in the majority of cases has shown the potential to cause
other issues and has been challenged [1, 3].
Numerous studies have looked at the effects that cold has
on tolerance of LBNP. The majority have used a reduction
in skin temperature and controlled the core temperature to
prevent a decrease and then subsequent shivering thermogenesis [4–7].
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Table 1: Participant characteristics (M ± SD).

20.3 ± 2.7
180.8 ± 5.7
81.6 ± 13.4
2.0 ± 0.2
8.1 ± 2.3
42.7 ± 5.1
1.1

LBNP

Post-LBNP

37.6
Rectal temperature (∘ C)

M ± SD
(𝑁 = 11)

Variable
Age (yr)
Height (cm)
Mass (kg)
𝐴 𝐷 (m2 )
% BF (skinfolds)
VO2max (mL⋅kg−1 ⋅min−1 )
Body density

Pre-LBNP

37.4
37.2
37.0
36.8

Note. 𝐴 𝐷 , body surface area; VO2max , maximal oxygen uptake.
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P < 0.05 compared to AMB

36.6
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The purpose of this investigation was to determine the
effects that decreasing the body’s core temperature has on tolerance of exposure to LBNP and the subsequent reduction in
central blood volume and whether that response is different
from previous studies.

AMB
COLD

Figure 1: Changes in rectal temperature (∘ C) (M ± 95% CI) during
pre-LBNP, LBNP, and post-LBNP periods.

2. Materials and Methods

Pre-LBNP
35
34
Mean skin temperature ( ∘ C)

2.1. Subjects. Eleven Caucasian male subjects between the
ages of 18 and 25 years volunteered for this investigation. Only
male subjects were used to limit thermoregulatory variables.
Participant characteristics are listed in Table 1. All subjects
were free of disease and were not taking any medication
that will influence cardiovascular or fluid regulation. Health
status was determined via a self-reported health history
questionnaire. Each subject was provided with and read and
signed an informed consent in accordance with the guidelines
set forth by the Kent State University Human Subjects Review
Board.
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2.2. Design. Participants underwent an exposure to LBNP
in a cold experimental trial in one visit (COLD) and an
exposure to LBNP in an ambient experimental trial (AMB)
in another visit. Both trials were staged in the Environmental
Chamber (Neslab, Napa, California), Figure 7, in the Kent
State Environmental Laboratory. The order was determined
in a counterbalanced manner. Participants refrained from
exercise and from consuming any alcohol or caffeine 24 hours
prior to the start of either trial. The two trials (COLD and
AMB) were separated by a minimum of 48 hours so that the
effects of prior cold exposure, which was confirmed verbally,
would not alter tolerance of temperature or of LBNP with the
subsequent trial which was verified verbally prior to the start
of the second trial.
2.3. Instrumentation. Prior to the start of the experimental
trial, participants were instructed to insert a rectal thermometer (ER 400-12, O.E. Meyer Co., Sandusky, OH) 13 cm
past the anal sphincter for continuous measurement of core
temperature. Skin thermistors (Model number 409 B, Yellow
Springs Instruments, Inc., Yellow Springs, OH) were applied
to the individual’s body and held in place by waterproof tape
(Hy-tape International, Patterson, NY). The thermistors were

0

5 20
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Time (min)
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Figure 2: Changes in mean skin temperature (∘ C) (M ± 95% CI)
during pre-LBNP, LBNP, and post-LBNP periods.

applied to the right forearm, triceps, chest, thigh, and calf [8].
Skin thermistors were applied and the participants were fitted
with a Polar heart rate monitor (Accurex Plus, Polar Electro,
Inc., Woodbury, NY) which was used to monitor heart rate.
Bioimpedance sensors (Cardiodynamics BioZ, San Diego,
CA) [9] were placed on both carotid arteries and the axillary
regions so that mean arterial blood pressure and stroke
volume were monitored using impedance cardiography. The
INVOS system was used for real-time monitoring of changes
in regional brain oxygen saturation (rSO2 ) of blood flow in
the frontal lobe of the brain (Somanetics Corp., Troy, MI) [10].
Subjects were fitted with one sensor on their forehead prior to
the start of the experimental trial and it remained there until
completion of the trial.

BioMed Research International

3
LBNP

Mean arterial pressure (mmHg)

∗
∗

100
95
90

∗

∗

∗

∗

∗

130

Post-LBNP

85
80

70

∗

0

30

60

90 105 115
Time (min)

120

100
90
80
∗

0

30

Pre-LBNP

LBNP

Post-LBNP

85

rSO2 (%)

Heart rate (beats/min)

∗

∗

∗

∗

55

60
55
∗

30

60

90

105

115

P < 0.05 compared
to AMB

120

125

Time (min)
AMB
COLD

Post-LBNP
∗

∗

∗

∗

70
65

0

125

75

60

50

LBNP

∗

80

65

120

Figure 5: Changes in stroke volume (mL × beat−1 ) (M ± 95% CI)
during the pre-LBNP, LBNP, and post-LBNP periods.
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Figure 3: Changes in mean arterial blood pressure (mmHg) (M ±
95% CI) during the pre-LBNP, LBNP, and post-LBNP periods.
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Figure 6: Changes in cerebral oxygenation (%) (M ± 95% CI) during
the pre-LBNP, LBNP, and post-LBNP periods.

Figure 4: Changes in heart rate (beats/min) (M ± 95% CI) during
the pre-LBNP, LBNP, and post-LBNP periods.

2.4. Protocol. Subjects were dressed in athletic shorts only for
both trials. Subjects positioned themselves in the LBNP box,
which is pictured in Figure 8, up to the level of the anterior
superior iliac spine. The subject then lied quietly on a table
(Hausmann Industries, Northvale, NJ) for the duration of the
trial. LBNP was applied at a level of −40 mmHg for both trials.
The LBNP box was placed in the chamber prior to cooling
and, for both trials, the top of the box was removed for the
initial exposure period. This insured that there was not any
increase in core temperature due to being sheltered from the
environmental stress. The COLD experimental trial consisted
of two components: an initial acute cold exposure (ACE) in
an environmentally controlled chamber (Neslab, Napa, CA)

followed by the LBNP application period. The acute cold
exposure was to last for 100 minutes unless the subject’s core
temperature dropped 1∘ C at which time the LBNP application
was initiated. LBNP application was terminated after 20
minutes or if the subject began experiencing nausea or lost
consciousness. The environmental chamber was controlled
within ±3∘ C of 10∘ C. There was a 15 min recovery period
after the trial. The AMB experimental trial took place in
the chamber with the temperature controlled within ±5∘ C of
23∘ C. LBNP was applied 100 minutes after initiation of the
trial and terminated after 20 minutes. There was a 15-minuterecovery period after the AMB trial.
2.5. Data Analysis. Means and standard deviations were
calculated for subject characteristics (age, height, mass, body
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core temperatures did drop more than 1∘ C during the COLD
trials so all subjects were initially exposed to cold for 100
minutes. However, skin temperature decreased during
COLD trial but did not change across time during the AMB
trial. Skin temperature was significantly less at each time
point for the COLD trial as compared to the AMB trial.
A Shapiro-Wilk’s test (𝑃 > 0.05) [11] showed that the temperature readings were approximately normally distributed
with the exception of the readings at one hundred thirty-five
minutes of the AMB trials. Partial eta squared was 0.334.

Figure 7: The exterior of the environmental chamber at the Kent
State Environmental Laboratory.

Figure 8: The LBNP box.

surface area, surface area-to-mass ratio, body fat percentages,
and VO2 ). The study included two treatments, LBNP in
ambient temperature and LBNP in cold. A group of male
college aged students (𝑁 = 11) were subjects. All data
were analyzed with SPSS software version 17 (Chicago, Ill).
Two separate two-way repeated measures analysis of variance
(ANOVA) by 10 time-points (0, 5, 20, 35, 50, 65, 80, 95, 110,
and 125 minutes) with two conditions (AMB and COLD),
were utilized to examine differences in 𝑇re and 𝑇sk .
Repeated measures analysis of variance was used to
determine if there was a difference in dependent variables
across time and condition (COLD and AMB). Specifically,
a 2 × 8 repeated measures ANOVA was used to analyze
mean arterial blood pressure, heart rate, stroke volume, and
regional oxygen saturation. For all comparisons, alpha was set
at 0.05.

3. Results
3.1. Rectal and Skin Temperature. Repeated measures
ANOVA demonstrated that there was a significant condition
by time interaction (𝑃 < 0.05) for both rectal and skin
temperature (Figures 1 and 2). Rectal temperature decreased
with time but was not different between conditions. Subjects

3.2. Mean Arterial Blood Pressure (MAP). MAP increased
during the pre-LBNP period for both the COLD and AMB
trials. The data for MAP is presented in Figure 3. Repeated
measures ANOVA demonstrated a significant condition by
time interaction (𝑃 < 0.05). The average change in pressure
was 6.18 mmHg for the AMB trials and 7.91 mmHg for the
COLD trials. MAP leveled off after the 60-minute measurement during the AMB trials. There was an average increase of
1.27 mmHg during the LBNP application for the AMB trials
and a decrease of 0.45 mmHg during the post-LBNP period.
During the COLD trials, there was an initial increase
in MAP (on average, the increase was 5 mmHg) 5 minutes
after application of LBNP followed by an average decrease
of 6 mmHg before the cessation of LBNP. This was likely
due to a further shift in fluids to the core with LBNP. The
overall average change in MAP during LBNP application was
−1 mmHg on average.
A Shapiro-Wilk’s test (𝑃 > 0.05) [9] showed that mean
arterial pressures were approximately normally distributed
with the exception of the reading at the sixty-minute mark
of the AMB trials. Partial eta squared was 0.290.
3.3. Heart Rate. Heart rate decreased by an average of 4 bpm
on average during the pre-LBNP period of the AMB trials and
by an average of 1 bpm on average during the COLD trials.
The data for heart rate is presented in Figure 4. Heart rate
dropped at the 60-minute measurement during the AMB trial
before a sharp increase prior to the application of LBNP. Heart
rate stayed steady during the pre-LBNP period of the COLD
trials. Repeated measures ANOVA demonstrated that there
was not a significant condition by time interaction (𝑃 > 0.05).
A Shapiro-Wilk’s test (𝑃 > 0.05) [9] showed that heart
rates were approximately normally distributed. Partial eta
squared was 0.148.
3.4. Stroke Volume. During the pre-LBNP period, there was
an average increase of 2.45 mL/beat during the AMB trials.
The data for stroke volume is presented in Figure 5. There was
an average increase of 5 mL/beat during the pre-LBNP of the
COLD trials. Repeated measures ANOVA demonstrated that
there was not a significant condition by time interaction (𝑃 >
0.05).
A Shapiro-Wilk’s test (𝑃 > 0.05) [9] showed that stroke
volumes were approximately normally distributed with the
exception of values taken at the thirty-minute mark and the
one hundred fifteen-minute mark during COLD trials. Partial
eta squared was 0.196.
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3.5. Cerebral Oxygenation. During the pre-LBNP period,
there was an average decrease of 1.62% during the AMB
trials and an average decrease of 9% during the COLD
trials. Application of LBNP caused an average decrease of
4.63% during the AMB trials. All of the AMB readings were
significantly higher than the COLD readings. The data for
cerebral oxygenation is presented in Figure 6.
During the COLD trials, there was an average decrease
of 1%. An average increase of 3.88% was observed during the
post-LBNP period of the AMB trials. There was an average
increase of 2.57% during the post-LBNP period. There was a
significant condition by time interaction (𝑃 < 0.05).
A Shapiro-Wilk’s test (𝑃 > 0.05) [9] showed that stroke
volumes were approximately normally distributed with the
exception of the readings at ninety minutes and one hundred
twenty-five minutes during the COLD trials. Partial eta
squared was 0.333.

4. Discussion
The present investigation was conducted to evaluate the
effects of cold exposure and lower body negative pressure
(LBNP) on cardiovascular and thermoregulatory homeostasis. The subjects in this study were exposed to cold for 100
minutes prior to exposure to LBNP in an effort to decrease
core temperature and evaluate the effects on a simulated
hemorrhage. When an individual is exposed to the cold,
both central and peripheral mechanisms are utilized so that
core temperature may be maintained. In an effort to retain
core temperature, shivering thermogenesis, in part, increases
metabolic heat production while peripheral vasoconstriction
minimizes heat loss [2].
This may be an advantage in treatment of hemorrhage.
The resultant reduction in central blood volume from hemorrhage elicits a left and upward shift of the Frank-Starling
curve, which leaves the cardiovascular system at risk for
collapse with any further reduction in volume [12]. The
mechanisms that the body uses in maintenance of core
temperature during cold exposure should attenuate this.
Hemorrhage leads typically to a reduction in central
blood volume. The response of the body is to maintain
perfusion of tissues. In order to do that, blood pressure
must be maintained. The data in this investigation indicates
that, during a simulated hemorrhage (LBNP) in ambient
temperature, there was a decrease in stroke volume, rSO2 ,
which is indicative of a fluid shift away from the core. The
reduction in central blood volume and blood pressure causes
compromised perfusion of tissues [4]. Cerebral blood flow
velocity was measured in a previous study by Wilson et al.
[13]. They used a head-up tilt to create the blood pooling in
the lower extremities. They used a tube lined suit for skin
surface cooling and found that cerebral blood flow velocity
was unchanged when the skin surface was cooled. They also
reported that the subjects did not demonstrate symptoms
of syncope with the cold exposure. Anecdotally, there were
6 subjects who reported symptoms of syncope during the
AMB trials, but there were no episodes of syncopal symptoms
during the COLD trials.
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A previous study by László et al. [14] suggested that there
was no significant increase in MAP with LBNP at −35 mmHg.
When the pressure increased to −55 and −65 mmHg, there
was an increase in MAP, so they concluded that there was a
dose-response relationship with LBNP and the cardiovascular system. The results of the present investigation agree with
studies done by Wilson et al. [13] and Keller et al. [7].
Increased afterload shifts the curve down and to the
right, which indicates that the subjects were able to maintain
perfusion of tissues in spite of a significantly lower rSO2 that
was seen during the COLD trials.
Durand et al. [6] found similar results to this investigation. A significant increase was reported in cumulative
stress index which showed improved tolerance to LBNP.
Researchers examined different negative pressures for 5
minutes as opposed to this investigation which used one
pressure for 20 minutes. The longer exposure time showed the
physiological pattern for each variable as a response to LBNP.
Cui et al. [5] examined central venous pressure with lower
body negative pressure. Five-minute intervals of LBNP at
various pressures were investigated as opposed to one 20minute interval for this investigation. Results were consistent
with this investigation, as Cui et al. found a significant
increase in central venous pressure with cold exposure.
In summary, the subjects were able to maintain blood
pressure much better in cold temperatures than in ambient
one. Cold may have delayed and/or minimized the effects
of lower body negative pressure on cardiovascular and
thermoregulatory variables. This is in agreement with other
studies that used a decrease in skin temperature as its only
stressor.

5. Limitations
One limitation of this investigation was that a wide range of
subject morphologies was observed. The weight range of our
subjects was from 55.8 kg to 100.24 kg. Subjects with a similar
height and weight may show trends of cardiovascular and
thermoregulatory variables. This would be due to similar total
fluid volume for each subject. There was also a wide range of
cold tolerance noted. One possible way to address this issue
would have been to pretest each individual and determine
their tolerance of LBNP prior to the trials. Another possible
limitation of this investigation was that oxygen saturation
in the periphery was not monitored and compared to brain
oxygen saturation. The significant main effect for condition
may have been due to vessel constriction secondary to the
cold response or it may have been due to the inability of the
NIRS unit to read the true values due to vessel constriction.

6. Conclusions
This investigation found that cold altered the physiological
response of the body to LBNP. This may be an indication
that cold may delay and/or minimize the onset of shock by
maintaining blood pressure for a longer period. This may
provide more time for an individual to receive more advanced
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interventions. Further investigation is warranted to provide
further support for this.

Abbreviations
LBNP:
COLD:
AMB:
rSO2 :

Lower body negative pressure
Cold trial
Ambient trial
Regional oxygen saturation.
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